(R)-(-)-3-Quinuclidinol CAS 25333-42-0 Puritas ≥99.0% Puritas Chiral ≥99.0%

Nomen chemicum | (R)-(-)-3-Quinuclidinol |
Synonyma | (R) -3-Quinuclinol |
CAS Number | 25333-42-0 |
CATTUS Number | RF-CC117 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C7H13NO |
M. Pondus | 127.18 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba vel Off-White pulveris |
Lepidium sativum RT (per GC) | Conformare cum Reference Standard |
Liquescens punctum | 212.0~224.0℃ |
Imprimis Rotationes [α]D20 | -40.0°~ -48.0° |
Humor (KF) | ≤0.50% |
Residere in Ignition | ≤0.50% |
Puritas | ≥99.0% |
Totalis immunditias | ≤1.00% |
Chiral Puritas | ≥99.0% |
Enantiomer | ≤1.00% |
Assay | 98.0%~101.0% (in Anhydrous Basis) |
Test Standard | Enterprise Standard |
Consuetudinem | Chiral Compositions;Pharmaceutical intermedia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine & humore


Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi (R)-(-)-3-Quinuclidinoli (CAS: 25333-42-0) magna qualitate, late in synthesi organica, synthesi pharmaceuticae intermediorum et Activa Pharmaceutical Ingrediens (API) synthesis.(R)-(-)-3-Quinuclidinol media in synthesi API fieri potest (CAS: 242478-38-2).(CAS: 242478-38-2) medicamentum antimuscarinicum est quod vesicae overactivae tractandae causa signa frequentiae, necessitatis vel incontinentiae adhibetur.(CAS: 242478-38-2) M3 receptor muscarinici hostis est qui enucleatus et emissus est ad curationem vesicae excitativae (pollakiuria) in Europa.M3 receptores in musculi contractiones vesicae lenis fere evocatis implicatae sunt, et receptores M2 etiam suspecti sunt ludi partes ob dominatum in musculo detrusore.Synthesis solifenacinorum involvit praeparationem racemicam 1-Phenyl-1,2,3,4-Tetrahydroisoquinolinam per cyclizationem N-(2-Phenylethyl)benzamidis, et reactionem subsequentem cum ethylo chloroformato et transesterificatione cum (R)-3-Quinuclidinolo. .Chromatographia chiralis praebet solitudinem desiderati diastereomeri.Vel, 1-Phenyl-1,2,3,4-Tetrahydroisoquinolino subjici potest resolutioni optica cum (+) Acido Tartarico priori curationi cum transesterificatione ethylo chloroformato et subsequente.